Scarica l'app Stockscreener
0.7774
6.49%
0.0474
Pre-mercato:
.82
0.0426
+5.48%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$0.73
Aprire:
$0.8
Volume 24 ore:
728.44K
Relative Volume:
2.57
Capitalizzazione di mercato:
$N/A
Reddito:
$80.72M
Utile/perdita netta:
$-56.64M
Rapporto P/E:
-3.1096
EPS:
-0.25
Flusso di cassa netto:
$-37.17M
1 W Prestazione:
+37.61%
1M Prestazione:
+34.08%
6M Prestazione:
+117.99%
1 anno Prestazione:
-35.85%
Intervallo 1D:
$0.75
$0.819
Intervallo di 1 settimana:
$0.64
$0.819
Portata 52W:
$0.33
$0.819
Vaxart Inc Stock (VXRT) Company Profile
Compare VXRT vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VXRT
Vaxart Inc
|
0.7774 | 0 | 80.72M | -56.64M | -37.17M | -0.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.03 | 126.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.81 | 82.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
756.76 | 47.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.07 | 44.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
314.36 | 35.08B | 4.98B | 69.60M | 525.67M | 0.5198 |
Vaxart Inc Stock (VXRT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-15 | Iniziato | Oppenheimer | Outperform |
| 2021-12-29 | Ripresa | Jefferies | Buy |
| 2021-11-02 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-06-29 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2021-06-24 | Iniziato | Jefferies | Buy |
| 2021-06-11 | Iniziato | Piper Sandler | Overweight |
| 2020-08-12 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-13 | Iniziato | B. Riley FBR | Buy |
Mostra tutto
Vaxart Inc Borsa (VXRT) Ultime notizie
3 Stocks Under $5 With Strong Analyst Upside Potential - Investing.com
3 Stocks Under $5 With Strong Analyst Upside Potential - Investing.com
Vaxart (OTCMKTS:VXRT) Stock Price Passes Above Fifty Day Moving AverageWhat's Next? - MarketBeat
Vaxart (VXRT) Stock Price, News & Analysis $VXRT - MarketBeat
Vaxart (VXRT) Stock Forecast and Price Target 2026 $VXRT - MarketBeat
Will Vaxart Inc. benefit from geopolitical trendsEarnings Risk Summary & Community Shared Stock Ideas - mfd.ru
Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026 - The Manila Times
Aug Patterns: Will Vaxart Inc outperform small cap indexes2025 Volatility Report & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Rate Hike: Whats the RSI of Vaxart Inc stockJuly 2025 Decliners & Low Risk Entry Point Tips - baoquankhu1.vn
Is Vaxart Inc. a play on infrastructure spending2025 Big Picture & Trade Opportunity Analysis - mfd.ru
Is Vaxart Inc.’s ROE strong enoughJuly 2025 Selloffs & Weekly High Return Opportunities - mfd.ru
Will Vaxart Inc. stock pay special dividendsEarnings Performance Report & Capital Efficiency Focused Strategies - mfd.ru
Will Vaxart Inc. stock continue dividend increases2025 Price Action Summary & Free High Return Stock Watch Alerts - mfd.ru
Vaxart soars on positive data from new norovirus vaccine trial - MSN
Vaxart (VXRT) Valuation After New npj Vaccines Data On Oral Norovirus Candidate In Breastfeeding Women - Yahoo Finance
Does Vaxart’s (VXRT) Early Norovirus Infant Data Hint At A Broader Oral Vaccine Platform Advantage? - simplywall.st
Vaxart, Inc. Leads Six-Month Stock Returns with 59.48% Gain - Markets Mojo
Vaxart (NASDAQ:VXRT) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Lobbying Update: $50,000 of VAXART INC. lobbying was just disclosed - Quiver Quantitative
The 3 Penny Stocks You Swore You’d Never Buy (But You’ll Check Anyway) - MarketBeat
Vaxart (VXRT) Advances Oral Vaccine with Promising Phase 1 Trial Results - GuruFocus
Vaxart Publishes Positive Phase 1 Trial Results for Oral Norovirus Vaccine in Breastfeeding Women, Highlighting Passive Immunity Transfer to Infants - Quiver Quantitative
Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants - Yahoo Finance
Vaxart secures $105.9 million more for COVID-19 pill vaccine trial - MSN
Vaxart’s Oral Vaccine Bet Hits A Funding Wall - Finimize
Can Celldex Therapeutics Inc disrupt its industry2025 Geopolitical Influence & Reliable Price Action Trade Plans - baoquankhu1.vn
Is Vaxart Inc. stock supported by strong fundamentalsJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда
Will Vaxart Inc. stock outperform international peersMarket Trend Review & Technical Pattern Recognition Alerts - Улправда
Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - The Manila Times
Aug Sentiment: How geopolitical tensions affect Vaxart Inc. stockQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - ulpravda.ru
Why Vaxart Inc. (NB11) stock attracts wealthy investorsEarnings Growth Patterns & Superior Capital Growth - ulpravda.ru
Vaxart Inc Stock Analysis and ForecastVolume Spike Alerts & Free Stock Index Interpretations - Early Times
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results - ADVFN
Moving Averages: What valuation ratios show for Vaxart Inc NB11 stock2025 AllTime Highs & Daily Oversold Stock Bounce Ideas - Bộ Nội Vụ
VAXART, INC. (VXRT) Reports Q2 Loss, Beats Revenue Estimates - MSN
Vaxart Q3 2025 Earnings Preview - MSN
Vaxart to relocate headquarters amid lease termination - MSN
Vaxart to Relocate Headquarters Amid Lease Termination - The Globe and Mail
Vaxart to terminate headquarters lease early, plans relocation in South San Francisco - Investing.com Nigeria
Vaxart (VXRT) terminates South San Francisco HQ lease and plans relocation - Stock Titan
Vaxart (NASDAQ:VXRT) Shares Cross Below 200-Day Moving AverageTime to Sell? - MarketBeat
Will Vaxart Inc. stock outperform tech sector in 2025July 2025 Action & Weekly Setup with ROI Potential - Улправда
Will Vaxart Inc. stock benefit from automationJuly 2025 Sentiment & Daily Stock Trend Watchlist - Улправда
Why Vaxart Inc. (NB11) stock fits value portfolios2025 Volatility Report & Growth Oriented Trade Recommendations - Улправда
Is Vaxart Inc. stock undervalued vs historical averagesWatch List & Community Consensus Picks - Улправда
Vaxart Inc Azioni (VXRT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.90%
2.73%
Capitalizzazione:
|
Volume (24 ore):